Brandon S. Hoffman

Array ( [id] => 1160520 [patent_doc_number] => 06759050 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-06 [patent_title] => 'Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith' [patent_app_type] => B1 [patent_app_number] => 09/453317 [patent_app_country] => US [patent_app_date] => 1999-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8791 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/759/06759050.pdf [firstpage_image] =>[orig_patent_app_number] => 09453317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1559508 [patent_doc_number] => 06436702 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Immortal cell line derived from grouper Epinephelus coioides and its application therein' [patent_app_type] => B1 [patent_app_number] => 09/450696 [patent_app_country] => US [patent_app_date] => 1999-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 17 [patent_no_of_words] => 7023 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436702.pdf [firstpage_image] =>[orig_patent_app_number] => 09450696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1287084 [patent_doc_number] => 06639057 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-28 [patent_title] => 'Monoclonal antibody against human telomerase catalytic subunit' [patent_app_type] => B1 [patent_app_number] => 09/424226 [patent_app_country] => US [patent_app_date] => 1999-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21165 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/639/06639057.pdf [firstpage_image] =>[orig_patent_app_number] => 09424226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1224564 [patent_doc_number] => 06699973 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-02 [patent_title] => 'Antibodies to peptides that target GIT receptors and related methods' [patent_app_type] => B1 [patent_app_number] => 09/443780 [patent_app_country] => US [patent_app_date] => 1999-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12596 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/699/06699973.pdf [firstpage_image] =>[orig_patent_app_number] => 09443780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 782682 [patent_doc_number] => 06991929 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-01-31 [patent_title] => 'Hepatitis A vaccines' [patent_app_type] => utility [patent_app_number] => 09/807659 [patent_app_country] => US [patent_app_date] => 1999-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4352 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/991/06991929.pdf [firstpage_image] =>[orig_patent_app_number] => 09807659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4244605 [patent_doc_number] => 06207168 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Vaccine composition for herpes simplex virus and methods of using' [patent_app_type] => 1 [patent_app_number] => 9/413512 [patent_app_country] => US [patent_app_date] => 1999-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12924 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207168.pdf [firstpage_image] =>[orig_patent_app_number] => 413512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7644044 [patent_doc_number] => 06428994 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'cDNA, genomic, and predicted protein sequences of learning-induced kinases' [patent_app_type] => B1 [patent_app_number] => 09/411628 [patent_app_country] => US [patent_app_date] => 1999-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 9 [patent_no_of_words] => 20705 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/428/06428994.pdf [firstpage_image] =>[orig_patent_app_number] => 09411628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 668163 [patent_doc_number] => 07094401 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-22 [patent_title] => 'HCV core protein binding agents for treatment of hepatitis C virus infection' [patent_app_type] => utility [patent_app_number] => 09/407432 [patent_app_country] => US [patent_app_date] => 1999-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 9327 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094401.pdf [firstpage_image] =>[orig_patent_app_number] => 09407432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1346041 [patent_doc_number] => 06579676 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-17 [patent_title] => 'Rapid mutational analysis method and compositions' [patent_app_type] => B1 [patent_app_number] => 09/400207 [patent_app_country] => US [patent_app_date] => 1999-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 13905 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/579/06579676.pdf [firstpage_image] =>[orig_patent_app_number] => 09400207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1350671 [patent_doc_number] => 06576240 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-10 [patent_title] => 'Antigenic structural peptide, antigenic and immunogenic compounds, and uses for detecting, preventing and treating an HCV infection' [patent_app_type] => B1 [patent_app_number] => 09/389756 [patent_app_country] => US [patent_app_date] => 1999-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5117 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/576/06576240.pdf [firstpage_image] =>[orig_patent_app_number] => 09389756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4266343 [patent_doc_number] => 06322788 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'Anti-bacterial antibodies and methods of use' [patent_app_type] => 1 [patent_app_number] => 9/378147 [patent_app_country] => US [patent_app_date] => 1999-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6478 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/322/06322788.pdf [firstpage_image] =>[orig_patent_app_number] => 378147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4367898 [patent_doc_number] => 06274560 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Cell-free synthesis of polyketides' [patent_app_type] => 1 [patent_app_number] => 9/374711 [patent_app_country] => US [patent_app_date] => 1999-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 17397 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274560.pdf [firstpage_image] =>[orig_patent_app_number] => 374711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1508420 [patent_doc_number] => 06441142 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Immunoassay for peanut allergen' [patent_app_type] => B1 [patent_app_number] => 09/336463 [patent_app_country] => US [patent_app_date] => 1999-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 12855 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/441/06441142.pdf [firstpage_image] =>[orig_patent_app_number] => 09336463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1570784 [patent_doc_number] => 06498244 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-24 [patent_title] => 'Adeno-associated virus capsid immunologic determinants' [patent_app_type] => B1 [patent_app_number] => 09/321589 [patent_app_country] => US [patent_app_date] => 1999-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4399 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/498/06498244.pdf [firstpage_image] =>[orig_patent_app_number] => 09321589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 971872 [patent_doc_number] => 06936257 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-08-30 [patent_title] => 'Recombinant Venezuelan equine encephalitis virus vaccine' [patent_app_type] => utility [patent_app_number] => 09/701299 [patent_app_country] => US [patent_app_date] => 1999-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3996 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/936/06936257.pdf [firstpage_image] =>[orig_patent_app_number] => 09701299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1414612 [patent_doc_number] => 06518045 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-11 [patent_title] => 'Feline cytokine protein' [patent_app_type] => B1 [patent_app_number] => 09/302495 [patent_app_country] => US [patent_app_date] => 1999-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 20 [patent_no_of_words] => 15533 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/518/06518045.pdf [firstpage_image] =>[orig_patent_app_number] => 09302495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1370307 [patent_doc_number] => 06558670 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-06 [patent_title] => 'Vaccine adjuvants' [patent_app_type] => B1 [patent_app_number] => 09/301829 [patent_app_country] => US [patent_app_date] => 1999-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 5865 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/558/06558670.pdf [firstpage_image] =>[orig_patent_app_number] => 09301829 [rel_patent_id] =>[rel_patent_doc_number] =>)